Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Very late-onset reversible cardiomyopathy in patients with chronic GvHD.
Kawano H, Tanaka H, Yamashita T, Hirata KI, Ishii S, Suzuki T, Wakahashi K, Kawano Y, Sada A, Minagawa K, Kawakami F, Itoh T, Baba A, Matsui T, Katayama Y. Kawano H, et al. Among authors: yamashita t. Bone Marrow Transplant. 2015 Jun;50(6):870-2. doi: 10.1038/bmt.2015.40. Epub 2015 Mar 23. Bone Marrow Transplant. 2015. PMID: 25798670 No abstract available.
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study.
Kim SW, Mori SI, Tanosaki R, Fukuda T, Kami M, Sakamaki H, Yamashita T, Kodera Y, Terakura S, Taniguchi S, Miyakoshi S, Usui N, Yano S, Kawano Y, Nagatoshi Y, Harada M, Morishima Y, Okamoto S, Saito AM, Ohashi Y, Ueda R, Takaue Y. Kim SW, et al. Among authors: yamashita t. Bone Marrow Transplant. 2009 Apr;43(8):611-7. doi: 10.1038/bmt.2008.372. Epub 2008 Nov 17. Bone Marrow Transplant. 2009. PMID: 19011665 Clinical Trial.
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT.
Oda K, Nakaseko C, Ozawa S, Nishimura M, Saito Y, Yoshiba F, Yamashita T, Fujita H, Takasaki H, Kanamori H, Maruta A, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Oda K, et al. Among authors: yamashita t. Bone Marrow Transplant. 2009 Jan;43(2):159-67. doi: 10.1038/bmt.2008.297. Epub 2008 Sep 1. Bone Marrow Transplant. 2009. PMID: 18762758
A higher number of infused CD34(+) cells has a positive impact on the clinical outcome after related PBSC transplantation.
Maie K, Fuji S, Tajima K, Tatsuno M, Yamagata S, Takahashi N, Ueda R, Hashimoto H, Takano K, Inoue Y, Ito A, Hayashi Y, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Heike Y, Yamashita T, Fukuda T. Maie K, et al. Among authors: yamashita t. Bone Marrow Transplant. 2014 Aug;49(8):1113-5. doi: 10.1038/bmt.2014.94. Epub 2014 May 5. Bone Marrow Transplant. 2014. PMID: 24797181 Clinical Trial. No abstract available.
A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.
Fuji S, Kim SW, Yano S, Hagiwara S, Nakamae H, Hidaka M, Ito T, Ohashi K, Hatanaka K, Takami A, Kurosawa S, Yamashita T, Yamaguchi T, Fukuda T. Fuji S, et al. Among authors: yamashita t. Bone Marrow Transplant. 2016 Mar;51(3):451-3. doi: 10.1038/bmt.2015.268. Epub 2015 Nov 9. Bone Marrow Transplant. 2016. PMID: 26551777 Clinical Trial. No abstract available.
Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation.
Tanaka Y, Kurosawa S, Tajima K, Tanaka T, Ito R, Inoue Y, Okinaka K, Inamoto Y, Fuji S, Kim SW, Tanosaki R, Yamashita T, Fukuda T. Tanaka Y, et al. Among authors: yamashita t. Bone Marrow Transplant. 2016 Apr;51(4):553-9. doi: 10.1038/bmt.2015.330. Epub 2016 Jan 11. Bone Marrow Transplant. 2016. PMID: 26752142 Clinical Trial.
6,889 results